Safety and efficacy of insulin detemir combined with OAD [oral anti-diabetic drug] versus insulin NPH [neutral protamine Hagedorn] [insulin-suspension-isophane] combined with OAD in type 2 mellitus.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Nov 2021

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Jul 2009 Actual end date (Jan 2004 ) added as reported by ClinicalTrials.gov.
01 Jul 2009 Actual patient number (477) added as reported by ClinicalTrials.gov.
03 Mar 2008 New trial record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com